Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Payables (2016 - 2026)

Kewaunee Scientific (KEQU) has 15 years of Payables data on record, last reported at $23.8 million in Q4 2025.

  • For Q4 2025, Payables rose 6.8% year-over-year to $23.8 million; the TTM value through Oct 2025 reached $23.8 million, up 6.8%, while the annual FY2025 figure was $28.0 million, 6.29% up from the prior year.
  • Payables reached $23.8 million in Q4 2025 per KEQU's latest filing, down from $26.8 million in the prior quarter.
  • Across five years, Payables topped out at $36.4 million in Q1 2022 and bottomed at $20.5 million in Q1 2021.
  • Average Payables over 5 years is $26.4 million, with a median of $26.0 million recorded in 2021.
  • The widest YoY moves for Payables: up 77.54% in 2022, down 32.05% in 2022.
  • A 5-year view of Payables shows it stood at $33.9 million in 2021, then plummeted by 32.05% to $23.0 million in 2022, then grew by 8.58% to $25.0 million in 2023, then decreased by 11.04% to $22.3 million in 2024, then rose by 6.8% to $23.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $23.8 million in Q4 2025, $26.8 million in Q3 2025, and $28.0 million in Q2 2025.